Linxin Xu

SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart

Chenguang Li, Jie Zhang, Mei Xue et al. · Cardiovascular Diabetology · 2019 · 560 citations · Full text

Empagliflozin improves diabetic renal tubular injury by alleviating mitochondrial fission via AMPK/SP1/PGAM5 pathway

Xiangyang Liu, Chaofei Xu, Linxin Xu et al. · Metabolism · 2020 · 111 citations

Empagliflozin prevents cardiomyopathy via sGC-cGMP-PKG pathway in type 2 diabetes mice

Mei Xue, Ting Li, Yue Wang et al. · Clinical Science · 2019 · 99 citations · Full text

Berberine Improves Insulin Sensitivity by Inhibiting Fat Store and Adjusting Adipokines Profile in Human Preadipocytes and Metabolic Syndrome Patients

Jing Yang, Jinhua Yin, Gao Hong-fei et al. · Evidence-based Complementary and Alternative Medicine · 2012 · 73 citations · Full text

Leptin-adiponectin imbalance as a marker of metabolic syndrome among Chinese children and adolescents: The BCAMS study

Ge Li, Linxin Xu, Yanglu Zhao et al. · PLoS ONE · 2017 · 49 citations · Full text